Cidofovir may be deleterious in BK virus-associated nephropathy.
Pallet
Nicolas
N
Burgard
Marianne
M
Quamouss
Ouadie
O
Rabant
Marion
M
Bererhi
Lynda
L
Martinez
Frank
F
Thervet
Eric
E
Anglicheau
Dany
D
Noel
Laure-Hélène
LH
Rouzioux
Christine
C
Legendre
Christophe
C
D000998:Antiviral Agents / Q000009:adverse effects*; D001739:BK Virus / Q000378:metabolism*; D000077404:Cidofovir; D003596:Cytosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006085:Graft Survival; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000821:virology*; D016030:Kidney Transplantation / Q000009:adverse effects; D063065:Organophosphonates / Q000009:adverse effects*; D027601:Polyomavirus Infections / Q000188:drug therapy*; D016896:Treatment Outcome; D014412:Tumor Virus Infections / Q000188:drug therapy*
D000998:Antiviral Agents; D063065:Organophosphonates; D003596:Cytosine; D000077404:Cidofovir